Arden Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Arden Trust’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,185	Closed	-$226K	–	378
2017 Q4	$226K	Sell	4,185 -178	-4%	-$9.74K	0.03%	329
2017 Q3	$249K	Sell	4,363 -9	-0.2%	-$527	0.04%	322
2017 Q2	$263K	Sell	4,372 -38	-0.9%	-$2.16K	0.04%	319
2017 Q1	$240K	Buy	+4,410	New	+$217K	0.04%	314

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Arden Trust's BIVV Position: Q1 2018 in Review

Arden Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,185 shares — an estimated $226K sold.

Arden Trust first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $263K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Arden Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Arden Trust sold 4,185 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $226K.
Arden Trust first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Arden Trust's Bioverativ Inc. Common Stock position peaked at $263K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Arden Trust's 13F filing for Q1 2018, filed 17 Apr 2018.